Allogeneic hematopoietic stem cell transplantation from an alternative stem cell source in Fanconi anemia patients: analysis of 47 patients from a single institution
AUTOR(ES)
Medeiros, C.R. de, Bitencourt, M.A., Zanis-Neto, J., Maluf, E.C.P., Carvalho, D.S., Bonfim, C.S., Funke, V.M., Setubal, D.C., Farah, N., Pasquini, R.
FONTE
Brazilian Journal of Medical and Biological Research
DATA DE PUBLICAÇÃO
28/08/2006
RESUMO
We transplanted 47 patients with Fanconi anemia using an alternative source of hematopoietic cells. The patients were assigned to the following groups: group 1, unrelated bone marrow (N = 15); group 2, unrelated cord blood (N = 17), and group 3, related non-sibling bone marrow (N = 15). Twenty-four patients (51%) had complete engraftment, which was not influenced by gender (P = 0.87), age (P = 0.45), dose of cyclophosphamide (P = 0.80), nucleated cell dose infused (P = 0.60), or use of anti-T serotherapy (P = 0.20). Favorable factors for superior engraftment were full HLA compatibility (independent of the source of cells; P = 0.007) and use of a fludarabine-based conditioning regimen (P = 0.046). Unfavorable factors were > or = 25 transfusions pre-transplant (P = 0.011) and degree of HLA disparity (P = 0.007). Intensity of mucositis (P = 0.50) and use of androgen prior to transplant had no influence on survival (P = 0.80). Acute graft-versus-host disease (GVHD) grade II-IV and chronic GVHD were diagnosed in 47 and 23% of available patients, respectively, and infections prevailed as the main cause of death, associated or not with GVHD. Eighteen patients are alive, the Kaplan-Meyer overall survival is 38% at ~8 years, and the best results were obtained with related non-sibling bone marrow patients. Three recommendations emerged from the present study: fludarabine as part of conditioning, transplant in patients with <25 transfusions and avoidance of HLA disparity. In addition, an extended family search (even when consanguinity is not present) seeking for a related non-sibling donor is highly recommended.
Documentos Relacionados
- Outcomes of allogeneic hematopoietic stem cell transplantation for lymphomas: a single-institution experience
- Body composition of Fanconi anemia patients after hematopoietic stem cell transplantation
- Unrelated hematopoietic stem cell transplantation in the pediatric population: single institution experience
- Epigenetic therapy in allogeneic hematopoietic stem cell transplantation
- Allogeneic hematopoietic stem cell transplantation in patients with advanced indolent lymphoproliferative disorders